Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 1
2018 3
2019 1
2020 2
2021 2
2022 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Salinomycin and dichloroacetate synergistically inhibit Lewis lung carcinoma cell proliferation, tumor growth and metastasis.
Skeberdytė A, Sarapinienė I, Krasko JA, Barakauskienė A, Žilionytė K, Prokarenkaitė R, Sužiedėlis K, Bukelskienė V, Jarmalaitė S. Skeberdytė A, et al. Among authors: krasko ja. Biochem Biophys Res Commun. 2020 Mar 19;523(4):874-879. doi: 10.1016/j.bbrc.2019.12.107. Epub 2020 Jan 16. Biochem Biophys Res Commun. 2020. PMID: 31955885
Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K, Bagdzevičiūtė U, Mlynska A, Urbštaitė E, Paberalė E, Dobrovolskienė N, Krasko JA, Pašukonienė V. Žilionytė K, et al. Among authors: krasko ja. Cancer Immunol Immunother. 2022 Nov;71(11):2691-2700. doi: 10.1007/s00262-022-03190-9. Epub 2022 Apr 1. Cancer Immunol Immunother. 2022. PMID: 35364740
Correction to: Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K, Bagdzevičiūtė U, Mlynska A, Urbštaitė E, Paberalė E, Dobrovolskienė N, Krasko JA, Pašukonienė V. Žilionytė K, et al. Among authors: krasko ja. Cancer Immunol Immunother. 2022 Nov;71(11):2701. doi: 10.1007/s00262-022-03207-3. Cancer Immunol Immunother. 2022. PMID: 35467108 No abstract available.
Defining Melanoma Immune Biomarkers-Desert, Excluded, and Inflamed Subtypes-Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns.
Mlynska A, Gibavičienė J, Kutanovaitė O, Senkus L, Mažeikaitė J, Kerševičiūtė I, Maskoliūnaitė V, Rupeikaitė N, Sabaliauskaitė R, Gaiževska J, Suveizdė K, Kraśko JA, Dobrovolskienė N, Paberalė E, Žymantaitė E, Pašukonienė V. Mlynska A, et al. Among authors: krasko ja. Biomolecules. 2024 Jan 31;14(2):171. doi: 10.3390/biom14020171. Biomolecules. 2024. PMID: 38397409 Free PMC article.
Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells.
Pašukonienė V, Mlynska A, Steponkienė S, Poderys V, Matulionytė M, Karabanovas V, Statkutė U, Purvinienė R, Kraśko JA, Jagminas A, Kurtinaitienė M, Strioga M, Rotomskis R. Pašukonienė V, et al. Among authors: krasko ja. Medicina (Kaunas). 2014;50(4):237-44. doi: 10.1016/j.medici.2014.09.009. Epub 2014 Oct 6. Medicina (Kaunas). 2014. PMID: 25458961 Free article.
14 results